PAVmed Inc. PAVM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 450.00% | 175.00% | 420.00% | -99.50% | -99.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 450.00% | 175.00% | 420.00% | -99.50% | -99.39% |
| Cost of Revenue | 197.56% | 169.44% | 77.08% | -96.02% | -97.54% |
| Gross Profit | -154.29% | -167.86% | 13.16% | 87.01% | 94.91% |
| SG&A Expenses | 25.09% | 41.91% | 13.82% | -61.27% | -65.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.44% | 47.73% | 31.90% | -61.44% | -67.80% |
| Operating Income | -48.93% | -47.54% | -31.15% | 58.16% | 65.54% |
| Income Before Tax | 46.46% | -105.71% | -341.42% | -109.90% | 17.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 46.46% | -105.71% | -341.42% | -109.90% | 17.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 201.24% | 191.01% | 416.96% | -82.97% | -90.14% |
| Net Income | 54.84% | -100.32% | -188.26% | -108.36% | -10.10% |
| EBIT | -48.93% | -47.54% | -31.15% | 58.16% | 65.54% |
| EBITDA | -49.22% | -48.34% | -32.57% | 57.48% | 64.92% |
| EPS Basic | 96.04% | -111.56% | -87.84% | -104.57% | 38.25% |
| Normalized Basic EPS | 81.75% | 78.36% | 101.90% | 95.05% | 93.99% |
| EPS Diluted | 96.04% | -143.76% | -1,014.74% | -120.35% | 38.24% |
| Normalized Diluted EPS | 81.75% | 18.28% | 123.19% | 78.01% | 93.99% |
| Average Basic Shares Outstanding | 940.05% | 241.79% | 148.05% | 115.44% | 97.57% |
| Average Diluted Shares Outstanding | 940.05% | -9.50% | -79.63% | -51.53% | 97.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |